GSK GlaxoSmithKline Plc

40.60-0.29 (-0.71%)
Close: September 16, 2019

40.610.01 (+0.03%)
After hours

Quote

Previous Close
$40.60
Day Range
$40.44-$40.80
52 Week Range
$36.41-$42.49
Volume
1,680,289
Avg Volume
2,216,453
Dividend TTM
$2.00 (4.92%)
Ex-Dividend Date
2019-08-08

Valuation

Market Cap
-
Enterprise Value (EV)
$121.27B
PE Ratio
17.46
EV/EBITDA
9.23
Price/Sales
2.27
Price/Book
16.65
PEG Ratio
5.51

Financials

Revenue
$41.10B
Gross Profit
$27.90B
EBITDA
$13.14B
EPS, ttm
$2.33
Profit Margin
11.75%
Revenue/Employee
$430.38K
Next Earnings Date
10/30/2019 (43 days)
Debt to Equity
598%
Debt
$126.31B
Cash
$5.04B
Net Debt
$121.27B

Performance

Beta
0.35
200 Day Moving Avg
$40.12
50 Day Moving Avg
$41.05
52 Week Change
3.55%
YTD Change
7.24%
1 Month Change
1.74%
3 Month Change
2.40%
6 Month Change
0.99%
1 Year Change
4.28%
2 Year Change
-2.81%
5 Year Change
-26.91%

Share Count

Shares Outstanding
-

GlaxoSmithKline Plc Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Emma Walmsley

Website: http://gsk.com

Description: GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Employees: 95,490